StockGist
Back
10-Q2025-08-11· merged:deepseek-v4-flash

G · Genpact Limited

0001398659-25-000098

SEC filing

Summary

Genpact's Q2 2025 revenue rose 6.6% YoY to $1.25B, with gross margin up 50bps to 35.9% and AOI margin at 17.3%, driven by Data-Tech-AI and Advanced Technology Solutions.

Key takeaways

Full analysis

Period Performance

Period Performance

Genpact's second quarter of 2025 showed solid year-over-year growth. Net revenues increased 6.6% to $1,254.4 million from $1,176.2 million in the prior year quarter. On a constant currency basis, revenue growth was 6.2%. Gross profit rose 8.1% to $450.1 million, with gross margin expanding 50 basis points to 35.9% due to improved operating leverage. Income from operations increased 5.4% to $179.4 million, but operating margin slightly declined from 14.5% to 14.3% as selling, general and administrative expenses grew faster at 11.2%, driven by higher headcount, strategic investments, and a higher allowance for credit losses. Net income grew 8.8% to $132.7 million, with net margin improving to 10.6% from 10.4%. Adjusted income from operations (AOI) increased 9.5% to $217.3 million, and AOI margin rose 40 basis points to 17.3%, supported by higher gross margin and other income, partially offset by higher SG&A.

Segment Dynamics

All three reportable segments contributed to revenue growth. High Tech and Manufacturing led with a 12.5% increase to $487.2 million, driven by ramp-ups from recently signed deals. Financial Services grew 6.1% to $338.6 million, largely due to increased demand for Advanced Technology Solutions. Consumer and Healthcare grew modestly at 1.1% to $428.6 million, also benefiting from technology solutions. In terms of profitability, segment AOI showed strong momentum: Financial Services AOI grew 19.5% to $63.5 million, Consumer and Healthcare AOI increased 7.5% to $76.0 million, and High Tech and Manufacturing AOI rose 20.7% to $90.0 million, all driven by higher revenues and operating efficiency. The disaggregated revenue view highlights the shift toward technology: Data-Tech-AI grew 9.7% to $599.3 million, and Advanced Technology Solutions surged 17.3% to $292.7 million, outpacing Digital Operations and Core Business Services growth of 4.0% and 3.8%, respectively.

Forward View

The MD&A does not provide specific numerical guidance for upcoming periods but discusses the macroeconomic environment. Management notes increased economic uncertainty due to tariff policies and geopolitical tensions, which could impact revenue growth and prolong sales cycles. However, the company expects that cash from operations, cash reserves, and debt capacity will be sufficient to finance operations, growth, dividends, and share repurchases. Strategic priorities include continued investment in data and AI solutions and technology services, which have been key growth drivers. The company also highlights the ramp-up of services from recently signed deals as a positive momentum factor.

Notes & Operating Detail

Balance Sheet & Liquidity

As of June 30, 2025, Genpact held $0.66B in cash and cash equivalents, with no short-term investments. Total debt stood at $1.29B, including $85M in short-term borrowings, $375.7M current portion of long-term debt, and $833.4M long-term debt. Shareholders' equity was $2.59B. The cash position provides adequate liquidity, though debt increased by $72.6M during the six-month period, mainly due to $85M drawn on the revolving credit facility. The company has $650M undrawn revolver capacity, offering additional flexibility.

Commitments & Contractual Obligations

Genpact has $28M in capital commitments for property, plant, and equipment as of June 30, 2025. Additionally, outstanding bank guarantees and letters of credit total $9.7M. The company also has deferred revenue (contract liabilities) of $146.9M, representing future performance obligations. No material off-balance-sheet commitments were disclosed.

Capital Allocation (buybacks, dividends, debt, capex)

  • Buybacks: In Q1 2025, the Board authorized a new $500M share repurchase program. During H1 2025, the company repurchased 1.9M shares for $93M at an average price of $48.98. Remaining authorization is $554M.
  • Dividends: Quarterly dividend increased 11.5% to $0.17 per share in February 2025. Total dividends paid in H1 2025 were $59.4M.
  • Debt: Net debt increased by $72.6M, driven by $85M in short-term borrowings, partially offset by $13.3M in term loan repayments.
  • Capex: Capital expenditures (PP&E and internal-use software) totaled $47.2M, or 1.9% of revenue, consistent with prior periods.

Segment / Geographic Mix (if disclosed at note level)

Genpact reports three segments: Financial Services (FS), Consumer and Healthcare (C&H), and High Tech and Manufacturing (HT&M). For the six months ended June 30, 2025:

  • FS revenue $665.8M (AOI $121.6M, margin 18.3%), grew 6.4% YoY.
  • C&H revenue $849.0M (AOI $146.4M, margin 17.2%), grew 2.6% YoY.
  • HT&M revenue $954.5M (AOI $170.1M, margin 17.8%), grew 11.7% YoY.

Revenue by service type (disaggregated in Note 19): Advanced Technology Solutions (ATS) $570.3M (23.1% of total), Core Business Services $1,899.1M (76.9%). Data-Tech-AI revenue was $1,181.2M (47.8%) vs Digital Operations $1,288.1M (52.2%). The mix shows a gradual shift toward higher-growth technology solutions.